X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12-12 | JNJ | Weinberger Mark A | Dir | P - Purchase | $147.22 | +1,000 | 1,000 | New | +$147,220 | ||||||
| D | 2024-08-30 | JNJ | Decker Robert J | VP Corporate Controller | S - Sale+OE | $165.06 | -5,635 | 19,721 | -22% | -$930,113 | |||||
2024-03-13 | JNJ | Broadhurst Vanessa | EVP, Global Corp Affairs | S - Sale | $162.16 | -8,891 | 15,043 | -37% | -$1,441,765 | ||||||
| D | 2024-02-09 | JNJ | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | S - Sale+OE | $156.27 | -59,397 | 141,416 | -30% | -$9,281,969 | |||||
2023-07-25 | JNJ | Fasolo Peter | EVP, CHRO | S - Sale | $170.33 | -20,000 | 102,696 | -16% | -$3,406,498 | ||||||
| D | 2023-07-26 | JNJ | Hait William | See Remarks | S - Sale+OE | $172.00 | -14,698 | 87,747 | -14% | -$2,528,056 | |||||
2023-06-12 | JNJ | Wengel Kathryn E | EVP, Chief TO, Risk Officer | S - Sale | $160.00 | -12,465 | 66,274 | -16% | -$1,994,400 | ||||||
2023-03-06 | JNJ | Swanson James D. | See Remarks | S - Sale | $154.66 | -1,062 | 9,215 | -10% | -$164,199 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |